Aurobindo Pharma recalls 20mg amphetamine tablets due to weight/thickness issues
Aurobindo Pharma USA Inc. recalls 20mg amphetamine tablets that may be out of specification for weight and thickness. This is a prescription-only product distributed by Aurobindo Pharma USA Inc. in the US.
Lower-risk recall
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Contact the company
What happened, in plain English
Aurobindo Pharma USA Inc. is recalling prescription 20mg amphetamine tablets that may be out of specification for weight and thickness. This could affect the product's accuracy and safety for users. Read more at govinfonow.com/recall/37921-aurobindo-pharma-recalls-20mg-amphetamine-tablets-due-to-weight-thickness.
Source Summary by GovInfoNow · govinfonow.com/recall/37921-aurobindo-pharma-recalls-20mg-amphetamine-tablets-due-to-weight-thickness · Updated October 5, 2026 · FDA enforcement record: FDA #D-0143-2020
Cite this page
“Aurobindo Pharma recalls 20mg amphetamine tablets due to weight/thickness issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37921-aurobindo-pharma-recalls-20mg-amphetamine-tablets-due-to-weight-thickness. Based on FDA recall #D-0143-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0143-2020%22&limit=1).
Why it’s dangerous
The tablets may be out of specification for weight and thickness, which could affect the product's accuracy and safety. This means the dosage might not be as intended, potentially leading to incorrect medication levels.
Who’s affected
Prescription users of the 20mg amphetamine tablets. People taking these medications for conditions like ADHD or narcolepsy are most at risk.
How to tell if you have this one
Check for the 20mg amphetamine tablets in 100-count bottles with NDC 13107-073-01, batch 07319032A1, and expiration date 02/2021. These are prescription-only products distributed by Aurobindo Pharma USA Inc.
- Brand
Aurobind: Aurobindo Pharma USA Inc- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC 13107-073-01, batch 07319032A1, and expiration date 02/2021 on the 20mg amphetamine tablets.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Aurobind: Aurobindo Pharma USA Inc recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0143-2020 (September 19, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0143-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.